Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
Transverse tubules (T-tubules) play a significant role in muscle contraction. However, the underlying mechanism of their ...
Earth’s ecosystems are governed by natural balance systems that respond to prolonged stress. Scientists say rising temperatures, species loss, and resource depletion are pushing those systems toward ...
One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published in Nature. Chromosomes are thread-like structures that carry a cell's ...
When DNA breaks, cells must repair it accurately to prevent harmful mutations. Researchers have discovered that during a key repair process called homologous recombination, the cell uses loops in its ...
On Wednesday, ahead of Nvidia's earnings next week, Deepwater Asset Management's Gene Munster said that he believes the AI giant faces a "Catch-22" that could unsettle investors no matter how strong ...
Hosted on MSN
Arctic Warming: A Very Bad Positive Feedback Loop
The oceans absorb 90% of the heat from greenhouse gasses, causing evermore ice to melt. Kansas mayor hit with criminal charges for allegedly voting as noncitizen in several elections Dolphins' Tyreek ...
The MarketWatch News Department was not involved in the creation of this content. RALEIGH, N.C., Oct. 29, 2025 /PRNewswire/ -- GeneVentiv Therapeutics, Inc., a privately held biotechnology company ...
RALEIGH, N.C., Oct. 29, 2025 /PRNewswire/ -- GeneVentiv Therapeutics, Inc., a privately held biotechnology company developing one-time gene therapies for rare and inherited diseases, today announced ...
AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback